Exalenz Bioscience Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0011048688
Medical Equipment, Supplies & Distribution
Sales 2018 | 13.14M 3.51M 1.31B 277M | Sales 2019 | 14.04M 3.75M 1.4B 296M | Capitalization | 77.67M 20.74M 7.77B 1.64B |
---|---|---|---|---|---|
Net income 2018 | -5M -1.34M -500M -105M | Net income 2019 | -1M -267K -100M -21.09M | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 782K 293M 61.72M | Net Debt 2019 | 3.09M 826K 309M 65.22M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 66 | 30/09/10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 28/01/19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 31/12/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 03/07/16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 31/12/05 |
Hanna Lerman
BRD | Director/Board Member | 51 | 15/04/15 |
1st Jan change | Capi. | |
---|---|---|
-4.59% | 184B | |
-2.80% | 103B | |
-4.87% | 67.59B | |
+15.82% | 46.93B | |
-8.89% | 43.87B | |
+8.28% | 41.2B | |
+17.21% | 30.47B | |
+13.59% | 24.16B | |
-7.36% | 23.57B |